Rubio's Presidential Bid, College Cybercrime, and Psychiatric Med Skeptics

Secretary of State Marco Rubio posts a video that seems like a campaign ad. The cybercrime group ShinyHunters attacks an edtech platform for ransom. Russia’s annual celebration of its WWII victory against the Nazis is pared down. The Dispatch’s Michael Reneau joins Clarissa Moll to discuss these headlines, and then Clarissa sits down with Dan Allender of The Allender Institute to discuss Health Secretary Robert F. Kennedy’s skepticism about antidepressants, and how Christians can thoughtfully approach the use of psychiatric medication. GO DEEPER WITH THE BULLETIN: Join the conversation at our Substack. Find us on YouTube. Rate and review the show in your podcast app of choice. ABOUT THE GUESTS: Michael Reneau is an executive editor at The Dispatch and is based in Greeneville, Tennessee. Prior to that, he was editor of WORLD Magazine and for several years was editor of a daily newspaper in East Tennessee. Dan Allender is a psychologist who pioneered a treatment approach that bridges the story of the gospel and the stories of trauma and abuse. Dan serves as a professor of counseling psychology at The Seattle School. He is the author of The Wounded Heart, The Healing Path, To Be Told, and God Loves Sex. Dan also co-hosts The Allender Center Podcast. ABOUT THE BULLETIN: The Bulletin is a twice-weekly news analysis podcast from Christianity Today, with editor-at-large Russell Moore and executive editor of news Clarissa Moll. Each episode offers commentary on current events and headlining news with a roundtable of premier guests, and shares a Christian perspective on issues that are shaping our world. The Bulletin listeners get 25% off CT. Go to https://orderct.com/THEBULLETIN to learn more. “The Bulletin” is a production of Christianity Today Producer: Clarissa Moll Associate Producer: Alexa Burke Editing and Mix: Kevin Morris Graphic Design: Rick Szuecs Music: Dan Phelps Executive Producer: Erik Petrik Senior Producer: Matt Stevens Learn more about your ad choices. Visit podcastchoices.com/adchoices